12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tramadol is an atypical analgesic with monoamine and modest mu opioid agonist activity. The purpose of this study was to evaluate: (1) the efficacy of extended-release (ER) tramadol in treating prescription opioid withdrawal and (2) whether cessation of ER tramadol produces opioid withdrawal.

          Related collections

          Author and article information

          Journal
          Drug Alcohol Depend
          Drug and alcohol dependence
          Elsevier BV
          1879-0046
          0376-8716
          Nov 01 2013
          : 133
          : 1
          Affiliations
          [1 ] University of Kentucky (UK), Department of Psychiatry, Lexington, KY 40509, USA; UK, Department of Behavioral Science, Lexington, KY 40502, USA; UK, Center on Drug and Alcohol Research, Lexington, KY 40502, USA. Electronic address: michelle.lofwall@uky.edu.
          Article
          S0376-8716(13)00185-3 NIHMS482600
          10.1016/j.drugalcdep.2013.05.010
          3786049
          23755929
          d5b891a5-f471-46a3-a8d0-8b0afd9ca106
          History

          Tramadol,Prescription opioid dependence,Opioid withdrawal,Efficacy,Treatment,Randomized clinical trial

          Comments

          Comment on this article